当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第29期
编号:11705597
子宫内膜息肉患者息肉组织中ER、PR、VEGF、MVD表达研究(3)
http://www.100md.com 2008年10月25日 《中国实用医药》 2008年第29期
     参考文献

    [1] Lydia J.Taylor,Tracy L.Jackson,Janet G.Reid,et al.The differential expression of oestrogen receptors,progesterone receptors,Bcl2 and ki-67 in endometrial polyps.Br J Obstet Gynaecol,2003,110:794-798.

    [2] 冯力民,王伟娟,张红霞,等.宫腔经手术治疗子宫内膜息肉的临床分析.中华妇产科杂志,2003,38(10):611-613.

    [3] Smith SK.Angiogenesis.Semin Report Endocrinol,1997,15(3):221-227.

    [4] Mohamed Shaarawy,Sherif A.Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer.acta oncologica,2001,40(4):513-518.

    [5] Fujiwaki R,Iida K,Kanasaki H.Cyclooxygenase-2 expression in endometrial cancer:correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase.Hum Pathol,2002,33(2):213-9.

    [6] Naresh B,Sengupta J,Bhargava.Immunohistological localisation of vascular endothelial growth factor in human endometrium.Indian.Physiol Pharmacol,1999,43(2):165-170.

    [7] Riboldi E,Musso T,Moroni E,et al.Cutting edge:proangiogenic properties of alternatively activated dendritic cells.J Immunol,2005,175(5):2788-2792.

    [8] Mimura K,Kono K,Takahashi A,et al.Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor22.Cancer Imm unol Imm unother,2007,56(6):761-770., 百拇医药(李晶华 王晓光 冯力民 张 华)
上一页1 2 3